Martin Patricia A. has filed 25 insider transactions across 2 companies since March 2023.
Most recent transaction: a disposition of 24999 shares of AN2 Therapeutics, Inc. ($ANTX) on March 19, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Not found | D | Stock Option (right to buy) | 24999 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.08% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Not found | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 30,276,230 | 9999.99% | 0.08% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Not found | D | Stock Option (right to buy) | 10362 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.03% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Not found | A | Stock Option (right to buy) | 10362 | $0.00 | 10,362.0000 | 30,276,230 | 9999.99% | 0.03% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Not found | A | Stock Option (right to buy) | 24999 | $0.00 | 24,999.0000 | 30,276,230 | 9999.99% | 0.08% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Not found | D | Stock Option (right to buy) | 23742 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.08% |
| March 13, 2026 | CYPHERPUNK TECHNOLOGIES INC. | $CYPH | Martin Patricia A. | Director | M | Common Stock | 94050 | $0.00 | 168,750.0000 | 41,444,979 | 125.90% | 0.23% |
| March 13, 2026 | CYPHERPUNK TECHNOLOGIES INC. | $CYPH | Martin Patricia A. | Director | M | Restricted Stock Units | 74700 | $0.00 | 0.0000 | 41,444,979 | 100.00% | 0.18% |
| March 13, 2026 | CYPHERPUNK TECHNOLOGIES INC. | $CYPH | Martin Patricia A. | Director | M | Restricted Stock Units | 94050 | $0.00 | 0.0000 | 41,444,979 | 100.00% | 0.23% |
| March 13, 2026 | CYPHERPUNK TECHNOLOGIES INC. | $CYPH | Martin Patricia A. | Director | M | Common Stock | 74700 | $0.00 | 74,700.0000 | 41,444,979 | 9999.99% | 0.18% |
| Feb. 20, 2026 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 30,276,230 | 9999.99% | 0.07% |
| Jan. 12, 2026 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Not found | A | Common Stock | 3650 | $0.00 | 16,905.0000 | 30,276,230 | 27.54% | 0.01% |
| Dec. 23, 2025 | CYPHERPUNK TECHNOLOGIES INC. | $CYPH | Martin Patricia A. | Director | A | Restricted Stock Units | 94050 | $0.00 | 94,050.0000 | 41,444,979 | 9999.99% | 0.23% |
| Nov. 11, 2025 | CYPHERPUNK TECHNOLOGIES INC. | $CYPH | Martin Patricia A. | Director | A | Restricted Stock Units | 74700 | $0.00 | 74,700.0000 | 41,444,979 | 9999.99% | 0.18% |
| Oct. 10, 2025 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Not found | A | Common Stock | 3274 | $0.00 | 13,255.0000 | 30,276,230 | 32.80% | 0.01% |
| July 10, 2025 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Not found | A | Common Stock | 3750 | $0.00 | 9,981.0000 | 29,828,227 | 60.18% | 0.01% |
| May 22, 2025 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Not found | A | Stock Option (Right to Buy) | 19111 | $0.00 | 19,111.0000 | 29,828,227 | 9999.99% | 0.06% |
| April 10, 2025 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Not found | A | Common Stock | 3065 | $0.00 | 6,231.0000 | 29,828,227 | 96.81% | 0.01% |
| Dec. 19, 2024 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Not found | A | Common Stock | 3166 | $0.00 | 3,166.0000 | 29,841,169 | 9999.99% | 0.01% |
| Oct. 2, 2024 | CYPHERPUNK TECHNOLOGIES INC. | $CYPH | Martin Patricia A. | Director | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 41,209,639 | 9999.99% | 0.06% |
| June 19, 2024 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Not found | A | Stock Option (Right to Buy) | 64503 | $0.00 | 64,503.0000 | 23,600,107 | 9999.99% | 0.27% |
| Jan. 29, 2024 | CYPHERPUNK TECHNOLOGIES INC. | $CYPH | Martin Patricia A. | Director | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 20,445,109 | 9999.99% | 0.12% |
| Aug. 23, 2023 | CYPHERPUNK TECHNOLOGIES INC. | $CYPH | Martin Patricia A. | Director | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 14,710,375 | 9999.99% | 0.10% |
| June 7, 2023 | AN2 Therapeutics, Inc. | $ANTX | Martin Patricia A. | Director | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2023 | CYPHERPUNK TECHNOLOGIES INC. | $CYPH | Martin Patricia A. | Director | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 11,323,909 | 9999.99% | 1.32% |